Overview
Yangki Seok practices practicing medicine in Daegu, Republic of Korea.
Seok is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Endoscopy.
They are actively involved in clinical research, co-authoring 43 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Yangki Seok
Is Yangki Seok a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Yangki Seok is classified as an Advanced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Yangki Seok participate in research or clinical trials?
Yes. Yangki Seok has published 43 articles and abstracts on conditions like Lung Cancer. You can view a list of Yangki Seok's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Lung CancerSeok isAdvanced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Experienced
- EndoscopySeok isExperienced. Learn about Endoscopy.
- Lung AdenocarcinomaSeok isExperienced. Learn about Lung Adenocarcinoma.